Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of glimepiride 1 mg
tablets (manufactured by Ranbaxy Laboratories Limited) with that of AMARYL® 1 mg tablets
following a single oral dose (1 x 1 mg tablet) in healthy, adult subjects under fasting
conditions.